These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14523781)

  • 21. [Adverse ocular effects of vaccinations].
    Ness T; Hengel H
    Ophthalmologe; 2016 Jul; 113(7):615-22. PubMed ID: 27357302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse ocular effects following influenza vaccination.
    Solomon A; Siganos CS; Frucht-Pery J
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():381-2. PubMed ID: 10624444
    [No Abstract]   [Full Text] [Related]  

  • 23. Solicited adverse events after influenza immunization among infants, toddlers, and their household contacts.
    Skowronski DM; Jacobsen K; Daigneault J; Remple VP; Gagnon L; Daly P; Arsenault G; Landry M; Pielak K; Duval B; Tam T; De Serres G
    Pediatrics; 2006 Jun; 117(6):1963-71. PubMed ID: 16740837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.
    Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S
    Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A painful red eye.
    Sharma NS; Ooi JL; Li MZ
    Aust Fam Physician; 2009 Oct; 38(10):805-7. PubMed ID: 19893822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model.
    Babiuk S; Skowronski DM; De Serres G; HayGlass K; Brunham RC; Babiuk L
    J Med Virol; 2004 Jan; 72(1):138-42. PubMed ID: 14635022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
    Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.
    Skowronski DM; De Serres G; Hebert J; Stark D; Warrington R; Macnabb J; Shadmani R; Rochette L; MacDonald D; Patrick DM; Duval B
    Vaccine; 2002 Jun; 20(21-22):2713-9. PubMed ID: 12034097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination.
    Kao CD; Chen JT; Lin KP; Shan DE; Wu ZA; Liao KK
    Clin Neurol Neurosurg; 2004 Mar; 106(2):136-8. PubMed ID: 15003306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophilic dermatosis of the hands after influenza vaccination.
    Wolf R; Barzilai A; Davidovici B
    Int J Dermatol; 2009 Jan; 48(1):66-8. PubMed ID: 19126054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular complications in 2 cases with porphyria.
    Altiparmak UE; Oflu Y; Kocaoglu FA; Katircioglu YA; Duman S
    Cornea; 2008 Oct; 27(9):1093-6. PubMed ID: 18812782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination and autoimmune rheumatic diseases.
    Conti F; Rezai S; Valesini G
    Autoimmun Rev; 2008 Dec; 8(2):124-8. PubMed ID: 18700175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
    Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal manifestations of ocular demodex infestation.
    Kheirkhah A; Casas V; Li W; Raju VK; Tseng SC
    Am J Ophthalmol; 2007 May; 143(5):743-749. PubMed ID: 17376393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
    Souayah N; Nasar A; Suri MF; Qureshi AI
    Vaccine; 2007 Jul; 25(29):5253-5. PubMed ID: 17560693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.